fda glp-1 warning october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The FDA has received hundreds

With flexible subscription options, theres a plan that works with your budget and lifestyle

Some people taking both medications report virtually no appetite at all, which can make eating feel like a chore rather than an enjoyable part of life

The company has already filed regulatory applications in the United States, Europe and other markets seeking approval for its oral GLP-1 candidate, orforglipron, for obesity

It's really Eric Topol (37:09): Very, again, you're being kind because it's, or I mean you're not

If supplementation is needed, choosing forms that dont wreck your digestive system matters enormously

At microdose levels, this risk is likely minimal, but patients with existing gallbladder disease should be monitored